Moleculin Biotech Sets 1 — for — 20 Reverse Stock Split for Oct. 20
Moleculin Biotech will implement a 1-for-20 reverse stock split effective at 12:01 a.m. Eastern Time on October 20, 2026. Shares will begin split-adjusted trading on the Nasdaq Capital Market on October 20 under the existing ticker MBRX. Outstanding common shares will fall from approximately 20,900,000 to 1,050,000; au